Skip to main content
Premium Trial:

Request an Annual Quote

Skin Health Startup Sequential Skin Raises $1.65M

NEW YORK — UK skin health startup Sequential Skin said on Monday that it has raised $1.65 million in an oversubscribed seed funding round.

The round was led by Metaplanet with participation from Scrum Ventures, SOSV, Genedant, and angel investor Ben Holmes. Sequential Skin said it has raised $2.15 million this year.

Sequential Skin offers an at-home test that includes an adhesive patch designed to collect a skin sample, which is returned to the company for next-generation sequencing and PCR analysis. The company said it uses the resulting data to generate a report detailing hydration, sensitivity response, firmness, sun protection, and antioxidant capacity of an individual's skin, as well as providing skin care recommendations.

The company, which also maintains operations in Singapore, said that it will use the new funding to expand its business-to-business efforts, as well as introduce a consumer-oriented test for the US market. Sequential Skin said the money will also be used to build its intellectual property portfolio and develop new technologies.

"We now have significant traction in assembling an extensive dataset on skin types from Asia, Europe, and the US — a great chance for us to discover novel biomarkers for skin conditions in different populations," Sequential Skin cofounder and CEO Oliver Worsley said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.